Analysis suppression

Analysis suppression is a reduction in the ability to think critically, form chains of reasoning, or evaluate a situation with ordinary depth.

As a drug effect it is acute and dose-proportional, fading as the substance wears off; it is distinct from any standing cognitive impairment or intellectual disability. It ranges from a mild blunting of reflective thought to a near-complete inability to follow or construct a logical argument.

It is among the more commonly reported cognitive effects across intoxicant classes. It is most commonly induced at moderate to high doses under depressants such as alcohol, alprazolam, and GHB, and under dissociatives such as ketamine and dextromethorphan. It also appears under cannabinoids like JWH-018 and 5F-AKB48, and under deliriants such as diphenhydramine, Amanita muscaria, and myristicin.

Analysis suppression is felt as a softening of critical thought: ideas arrive and pass without being examined, contradictions go unnoticed, and conclusions form without any felt sense of having reasoned toward them. It commonly comes with a narrowed attention span and difficulty holding multiple concepts in mind at once.

Attempting to think through a problem often produces a sense of the thought dissolving before it reaches completion. At high doses, particularly under dissociatives, this can deepen until even simple causal relationships feel opaque.

Analysis suppression arises through different pathways depending on the drug class:

• Depressants — enhance GABAergic inhibition across prefrontal circuits, reducing the sustained attention and working memory that analysis requires.
• Dissociatives — block NMDA receptors, fragmenting the neural integration underlying coherent reasoning.
• Cannabinoids — act on CB1 receptors in prefrontal and hippocampal regions, disrupting the encoding and retrieval of information mid-thought.
• Deliriants — block muscarinic acetylcholine receptors, heavily impairing working memory and executive function.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses reliably deepen the effect, but individual sensitivity differs considerably. It is more pronounced in those unaccustomed to a given substance, and most apparent in settings that demand clear thinking, where the gap between normal capacity and current function becomes obvious.

Expectation compounds it — entering an experience already uncertain of one's own thinking heightens the felt sense of impairment. A relaxed, low-demand setting and familiarity with the substance tend to reduce it.